US Congress grills Teva CEO on Copaxone price hikes - Globes
Teva Pharmaceuticals (@TevaUSA) / Twitter
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M | Fierce Pharma
23 Teva Pharmaceuticals Open New Logistic Centre In Israel Photos and Premium High Res Pictures - Getty Images
Teva Pharmaceuticals - Wikipedia
Teva CEO stands down during troubled times - MedCity News
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva Announces Changes to Executive Management Team | Business Wire
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health | Reuters
Teva names Kåre Schultz as new CEO
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic Group - The Economic Times
Teva Pharmaceuticals - Wikipedia
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO tells PM no bending on mass redundancy plan
teva ceo News and latest stories | The Jerusalem Post
Teva buys Anda for $500 million - ISRAEL21c
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva Pharmaceuticals - Wikiwand
Teva Announces New Organization Structure and Leadership Changes | Business Wire
President and CEO of North Wales' Teva Pharmaceutical Steps Down
Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. | Barron's
